Watch for Liontrust's next moves—whether they seek board representation, push for strategic alternatives, or increase their stake. The activist filing combined with improving fundamentals (raised guidance) creates a catalyst for shareholder engagement. Monitor for a proxy statement or further 13D amendments outlining specific demands.
Price Chart
Executive Summary
Liontrust Investment Partners LLP, a UK-based investment firm, filed a Schedule 13D disclosing beneficial ownership of 5,194,322 shares of MaxCyte (MXCT), representing 5.03% of the outstanding common stock. The filing indicates an activist intent, with the stated purpose of evaluating potential changes to the issuer's business or strategy. This comes one day after MaxCyte reported strong preliminary Q3 2026 results and raised full-year guidance, suggesting the activist stake was built during a period of operational improvement.
Key Financial Metrics
Key Facts
- Liontrust Investment Partners LLP disclosed a 5.03% stake in MaxCyte (5,194,322 shares) via Schedule 13D filed October 15, 2026.
- The filing states the investment is for the purpose of evaluating potential changes to the issuer's business or strategy, indicating activist intent.
- The stake was built through a series of trades from September to October 2026, including net selling in early September and a large buy on October 14.
- This filing follows MaxCyte's preliminary Q3 2026 earnings pre-announcement on October 14, which showed core revenue of ~$8.1M (+26% YoY) and raised full-year 2026 guidance to ~$34M.
Financial Impact
5.03% stake valued at approximately $6.5 million based on recent trading prices around $1.26 per share.
Risk Factors
- Activist may push for changes that management resists, leading to a proxy fight or distraction.
- Liontrust's track record and specific demands are unknown; the filing lacks detail on their intended strategy.
- The stock has declined significantly from its June 2025 market value of ~$2.18 per share, indicating potential underlying business challenges despite recent revenue improvement.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13D Filing (Primary) | 0001544204-26-000009 |
| Document: 0001544204-26-000009-index.html | 0001544204-26-000009 |
| Document: 0001544204-26-000009.txt | 0001544204-26-000009 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 12d ago | SC 13D | $1.30 $1.43 | ▲ +10.00% | ▲ +11.01% | $1.57 (+20.38%) |
Oct 14, 2026 13d ago | 8-K | $1.25 $1.47 | ▲ +17.60% | ▲ +17.15% | $1.57 (+25.20%) |
Apr 29, 2026 25w ago | DEFA14A | $0.8800 $0.8720 | ▼ −0.91% | ▼ −2.64% | $1.57 (+77.84%) |
Mar 24, 2026 30w ago | Press Release | $0.6900 $0.7440 | ▼ −7.83% | ▼ −8.07% | $1.57 (−126.81%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers